Hub : Traits :

Diastolic blood pressure, automated reading

1672 significantly associated models · 403 unique genes.

Significant Loci

# chr p0 p1 # assoc genes # joint genes best TWAS P best SNP P cond SNP P % var exp joint genes
1 1 7686056 9571422 3 1 4.0e-14 8.8e-13 1.8e-02 89 RERE
2 1 11032827 12600396 4 4 9.2e-26 3.6e-32 NaN NaN CLCN6 MTHFR
3 1 37730550 39147240 1 1 4.0e-08 1.4e-07 1.5e-02 78 SF3A3
4 1 43073464 44618031 7 1 1.7e-11 9.3e-11 3.6e-02 90 HYI
5 1 112312154 114366434 9 3 1.2e-12 1.2e-13 3.7e-08 45 SLC16A1 WNT2B
6 1 183961643 185416670 1 1 3.7e-08 1.5e-06 6.3e-01 99 EDEM3
7 1 201158976 202607593 3 1 1.8e-09 7.0e-13 9.6e-10 27 LMOD1
8 1 230142626 231548480 1 1 7.2e-12 8.9e-13 5.7e-07 51 AGT
9 1 242590540 244359621 3 1 3.8e-22 3.8e-22 1.0e+00 100 RP11-261C10.5
10 2 72925857 74654861 3 1 3.5e-08 1.2e-07 3.4e-01 97 NAT8
11 2 95420294 98024837 11 1 1.5e-13 3.0e-13 1.0e+00 100 ADRA2B
12 2 112143413 113572357 1 1 1.9e-08 3.9e-09 4.9e-04 65 TMEM87B
13 2 134513621 137435625 5 1 5.2e-09 4.5e-08 9.2e-01 100 LOC100129961
14 2 147905651 149475737 2 1 6.7e-08 5.8e-08 1.0e+00 100 ACVR2A
15 2 158332890 160006143 1 1 2.4e-10 8.2e-12 9.9e-03 86 CCDC148
16 2 171867383 173555880 3 1 5.8e-09 5.3e-09 1.0e+00 100 DYNC1I2
17 2 182305254 184084221 1 1 2.3e-11 1.7e-17 2.1e-08 57 PDE1A
18 2 189930854 192525536 7 2 5.0e-12 1.1e-07 6.5e-01 99 GLS MSTN
19 3 40537829 42967174 3 2 1.0e-22 6.9e-21 1.7e-01 98 CTNNB1 ULK4
20 3 47204518 50833360 20 2 3.3e-14 3.3e-11 7.0e-01 100 NME6 RNF123
21 3 56608033 58854266 3 1 3.7e-12 1.7e-11 2.2e-01 97 FLNB
22 3 107181540 108633112 1 1 2.8e-07 1.7e-07 1.0e+00 100 IFT57
23 3 121346656 122860765 4 1 1.6e-09 9.3e-09 3.2e-01 97 RP11-299J3.8
24 3 123792729 125314016 1 1 2.4e-10 2.4e-09 4.9e-01 99 ITGB5
25 3 133088362 134770520 3 2 7.7e-08 4.2e-08 1.0e+00 100 RP11-375I20.6 RYK
26 3 157125828 159106064 3 1 1.2e-10 1.6e-09 7.4e-01 100 RSRC1
27 4 17104059 18507692 1 1 8.4e-10 4.0e-08 1.1e-01 92 DCAF16
28 4 80488345 82578407 2 1 2.5e-10 2.3e-34 7.3e-26 26 C4orf22
29 4 102852939 104374596 1 1 3.7e-08 1.6e-19 2.5e-21 -10 MANBA
30 4 119605671 120922444 1 1 2.2e-07 2.2e-08 4.9e-03 75 C4orf3
31 5 60903201 62529686 1 1 6.8e-09 2.3e-11 9.4e-05 66 KIF2A
32 5 87104604 88677293 1 1 1.3e-08 6.3e-09 1.9e-01 95 LINC00461
33 5 95519506 97065386 2 1 1.1e-08 9.6e-09 2.8e-01 96 ERAP2
34 5 121983336 123649166 3 1 3.9e-13 2.9e-13 1.4e-03 81 KRT8P33
35 5 172620700 174088123 1 1 4.7e-17 1.5e-17 1.0e+00 100 CPEB4
36 6 25285943 26689223 1 1 1.9e-10 2.6e-15 4.2e-12 23 U91328.21
37 6 78880271 81763771 4 3 2.8e-12 1.7e-12 8.7e-02 94 BCKDHB IRAK1BP1
38 6 108994161 110396540 1 1 2.2e-07 2.1e-08 1.3e-03 67 CD164
39 6 115569351 117078784 1 1 4.1e-07 1.4e-06 4.3e-02 82 FRK
40 6 118089396 119728438 2 1 3.7e-08 3.8e-08 2.4e-01 95 CEP85L
41 6 126271503 128536730 2 1 4.1e-08 1.1e-18 4.8e-12 39 C6orf174
42 6 146826657 148410391 2 1 4.3e-09 4.0e-08 2.5e-01 96 STXBP5
43 7 6502367 7988091 1 1 3.8e-09 2.6e-08 4.8e-01 98 C1GALT1
44 7 45255940 46658015 1 1 3.2e-08 8.6e-13 1.4e-06 55 IGFBP3
45 7 73017005 75842792 10 2 4.8e-11 8.4e-08 3.3e-01 97 NCF1 STAG3L1
46 7 89096541 90739777 5 1 1.4e-10 1.9e-10 2.0e-01 96 GTPBP10
47 7 98915958 101185166 11 8 1.7e-14 1.3e-12 1.0e+00 100 ACHE GIGYF1 SRRT STAG3 TRIP6 ZKSCAN1
48 7 149563894 150916539 1 1 1.3e-10 1.5e-11 8.0e-09 27 GIMAP7
49 8 8092025 13120332 38 3 2.7e-19 4.1e-19 1.5e-02 93 MSRA NEIL2 PPP1R3B
50 8 22687572 24094711 1 1 4.0e-08 8.0e-08 2.2e-01 95 SLC25A37
51 8 95139766 96825195 3 1 3.0e-09 3.9e-10 1.0e-02 83 NDUFAF6
52 8 119737284 121136001 1 1 1.0e-17 6.1e-18 1.0e+00 100 NOV
53 9 138875850 140268976 1 1 3.1e-07 1.7e-10 6.4e-11 -5 AGPAT2
54 10 18221643 19637020 1 1 6.0e-11 3.2e-17 2.7e-14 19 NSUN6
55 10 21123825 22724472 1 1 2.9e-08 5.5e-08 6.3e-02 88 MLLT10
56 10 63856856 66034105 4 3 1.8e-21 7.4e-17 2.0e-01 98 NRBF2 REEP3 RP11-436D10.3
57 10 95379543 97055832 2 2 5.2e-10 1.0e-13 3.0e-03 84 HELLS NOC3L
58 10 103572925 105850787 6 1 2.4e-17 9.5e-17 4.3e-02 94 NT5C2
59 10 114740745 116183647 1 1 1.9e-10 7.0e-22 1.2e-17 21 CASP7
60 11 1242690 2640824 1 1 2.2e-08 2.4e-11 5.3e-06 54 TNNT3
61 11 9003306 11027552 2 2 1.1e-12 5.5e-15 2.2e-02 91 ADM SWAP70
62 11 12611333 14975818 2 2 9.5e-08 5.5e-10 3.6e-04 67 ARNTL SPON1
63 11 46570859 48783497 9 1 1.4e-10 4.7e-10 7.9e-03 82 ACP2
64 11 56774260 58178587 1 1 5.4e-08 1.2e-06 4.6e-02 83 MED19
65 11 64721908 66333072 3 2 1.4e-11 4.8e-11 1.9e-03 78 FIBP SIPA1
66 11 76673980 78578480 8 3 1.1e-08 7.4e-08 1.0e+00 100 INTS4 RP11-7I15.3 RP11-91P24.7
67 11 94199272 95663017 1 1 3.7e-10 3.2e-11 1.9e-02 88 SESN3
68 11 99859184 101559718 2 1 2.1e-36 4.8e-35 1.2e-01 98 TMEM133
69 11 106485489 107882823 1 1 8.2e-08 6.9e-10 4.2e-04 67 RP11-819C21.1
70 11 119392654 120797604 1 1 4.1e-07 8.7e-07 6.9e-01 99 OAF
71 11 129575976 130992111 1 1 1.3e-07 3.5e-16 8.8e-11 37 ADAMTS8
72 12 49780778 51912062 6 1 1.9e-15 1.8e-15 1.0e+00 100 CERS5
73 12 52742148 54146451 1 1 3.8e-08 1.4e-08 1.1e-01 92 TENC1
74 12 89286081 90799212 1 1 1.1e-08 8.9e-16 2.0e-09 44 ATP2B1
75 12 110199401 113517494 20 10 7.0e-41 1.7e-54 NaN NaN ACAD10 ADAM1A ALDH2 NAA25 PPTC7 SH2B3 TRAFD1
76 12 122625212 124774793 13 6 1.8e-14 5.9e-13 1.0e+00 100 ABCB9 MPHOSPH9 PITPNM2 RP11-282O18.3 SETD8
77 14 22670975 24125886 2 1 6.4e-09 7.4e-07 1.3e-03 58 HAUS4
78 14 55273730 56741515 1 1 2.6e-07 1.9e-08 4.2e-03 74 KTN1-AS1
79 15 39530508 43198430 21 10 3.7e-14 8.9e-13 NaN NaN CHP1 EIF2AK4 MAPKBP1 OIP5-AS1 PLA2G4B RP11-23P13.4 RP11-23P13.6 RP11-23P13.7 RPAP1
80 15 48352252 49794848 1 1 1.3e-11 1.9e-08 2.9e-01 96 CEP152
81 15 70697945 72771648 1 1 3.2e-08 3.7e-09 3.7e-02 88 THSD4
82 15 73933444 76108550 13 1 3.1e-28 1.0e-27 8.1e-03 94 MPI
83 15 77888924 79802863 2 1 2.6e-12 5.5e-12 3.6e-02 91 ADAMTS7
84 15 80377452 81936479 1 1 3.3e-10 2.4e-10 1.0e+00 100 KIAA1199
85 15 83167559 84434423 1 1 3.4e-07 1.3e-06 7.1e-02 86 BTBD1
86 15 90712555 92135418 2 1 3.6e-27 4.8e-24 7.8e-01 100 FES
87 16 1381714 2713729 1 1 7.8e-08 1.8e-08 8.3e-02 90 SLC9A3R2
88 16 3025993 4696654 2 2 2.8e-07 3.0e-08 1.2e-01 92 AC006111.1 RP11-462G12.1
89 16 29850705 31892919 18 1 1.5e-11 4.0e-10 4.1e-02 89 KAT8
90 16 55526487 57089130 1 1 1.8e-07 8.3e-07 1.5e-01 91 GNAO1
91 16 68523336 70063989 3 1 1.7e-09 4.6e-08 8.3e-02 90 SNTB2
92 16 81966047 84527021 1 1 1.1e-11 8.3e-13 1.6e-02 89 CDH13
93 17 1508522 2923933 1 1 4.9e-11 1.6e-09 1.0e+00 100 SRR
94 17 3208350 5323989 4 3 1.8e-09 7.1e-10 9.9e-05 60 ANKFY1 ARRB2 RP11-141J13.5
95 17 6397773 8484683 8 3 1.6e-08 3.7e-10 2.6e-01 97 DLG4 LSMD1 YBX2
96 17 14714000 16109675 1 1 2.6e-07 1.0e-07 3.4e-02 84 AC005517.3
97 17 29894732 31346135 1 1 3.1e-08 4.4e-07 1.8e-01 93 RHBDL3
98 17 42413481 43570226 3 1 7.0e-13 1.4e-11 1.3e-01 95 NMT1
99 17 46888301 48347817 1 1 8.2e-10 4.0e-10 2.0e-05 54 RP5-1029K10.2
100 17 56487887 57920532 2 1 2.9e-07 1.5e-07 5.9e-02 87 AC099850.1
101 17 76087754 77462467 1 1 5.8e-08 2.1e-08 1.0e+00 100 USP36
102 19 21206463 22643745 1 1 2.1e-07 3.3e-06 9.3e-02 87 ZNF100
103 19 29606361 31013761 1 1 5.9e-17 6.3e-19 2.7e-03 89 CCNE1
104 20 9925555 11347455 1 1 4.9e-10 2.6e-22 2.5e-19 14 JAG1
105 20 18506005 20398583 1 1 4.0e-09 1.3e-09 1.1e-01 93 SLC24A3
106 20 29833609 31312916 3 1 1.3e-10 2.1e-07 2.6e-01 95 C20orf160
107 20 46551079 48140682 1 1 1.4e-08 3.2e-11 6.6e-13 -17 PREX1
108 20 56858751 58262841 1 1 9.5e-08 4.8e-18 5.7e-14 25 NELFCD
109 20 61522825 62912463 6 3 1.1e-10 1.5e-10 1.0e+00 100 GMEB2 STMN3 TCEA2
110 21 29683463 31086816 1 1 1.4e-07 7.7e-07 6.1e-03 69 RWDD2B
111 22 27445437 28889735 1 1 2.3e-07 1.1e-09 1.0e-03 71 MN1

Pleiotropic Associations

Trait chisq ratio # genes+ # genes++ % genes++ corr corr P genes
Alzheimer’s Disease (in mother) 1.23 2 0 0.0 0.00 1.0e+00 KAT8 STAG3
Alzheimer’s Disease (including proxy) 1.44 3 3 9.1 0.00 1.0e+00 KAT8 STAG3 ZKSCAN1
Crohns Disease (2017) 1.91 7 4 12.1 0.50 2.6e-01 AGPAT2 ERAP2 GIGYF1 RNF123 RP11-436D10.3 STMN3 TRAFD1
Irritable Bowel Disease (IBD) 1.95 9 6 18.2 0.64 4.5e-02 AGPAT2 ERAP2 GIGYF1 GMEB2 RNF123 RP11-436D10.3 STMN3 TRAFD1 TRIP6
Ulcerative Colitis (UC) 1.61 3 2 6.1 0.00 1.0e+00 OIP5-AS1 RNF123 STMN3
Major Depression (MDD) 1.33 1 0 0.0 0.00 1.0e+00 NT5C2
Reaction Time 2.05 5 3 9.1 -0.97 2.9e-04 ACAD10 ALDH2 DLG4 NAA25 SH2B3
Verbal and Numeric Reasoning (VNR) 1.64 8 4 12.1 0.80 1.8e-02 ABCB9 DCAF16 IRAK1BP1 LINC00461 MPHOSPH9 NAT8 RNF123 U91328.21
Breast Cancer 1.81 6 3 9.1 -0.17 7.5e-01 CPEB4 FES FIBP MLLT10 RP11-436D10.3 TNNT3
Ovarian Cancer 1.08 1 1 3.0 0.00 1.0e+00 MLLT10
Prostate Cancer 1.28 1 0 0.0 0.00 1.0e+00 STMN3
Age at First Birth 1.60 1 1 3.0 0.00 1.0e+00 RNF123
Body Mass Index (BMI) (2010) 1.71 1 0 0.0 0.00 1.0e+00 STAG3L1
Coronary Artery Disease (CAD) 2.26 2 1 3.0 0.00 1.0e+00 ACAD10 ADAMTS7
Crohns Disease (2012) 1.90 4 3 9.1 -0.47 5.3e-01 ERAP2 RNF123 RP11-436D10.3 STMN3
Fasting Glucose 1.40 1 1 3.0 0.00 1.0e+00 ACP2
HbA1C 1.20 1 0 0.0 0.00 1.0e+00 ADAM1A
HDL Cholesterol 1.55 1 1 3.0 0.00 1.0e+00 ACP2
LDL Cholesterol 1.59 3 1 3.0 0.00 1.0e+00 ACAD10 ALDH2 SH2B3
Lupus 1.33 1 0 0.0 0.00 1.0e+00 MSRA
Neuroticism 1.61 4 1 3.0 0.57 4.3e-01 ADM LINC00461 MSRA RP11-462G12.1
Primary Biliary Cirrhosis 1.51 3 1 3.0 0.00 1.0e+00 ACAD10 MANBA SH2B3
Rheumatoid Arthritis 1.47 2 1 3.0 0.00 1.0e+00 ALDH2 SH2B3
Schizophrenia 1.99 12 3 9.1 0.09 7.6e-01 ABCB9 CERS5 DYNC1I2 FES GIGYF1 MPHOSPH9 MSRA NT5C2 RERE RP11-261C10.5 RP11-282O18.3 SETD8
Triglycerides 1.43 3 1 3.0 0.00 1.0e+00 KAT8 MSRA NRBF2
Ulcerative Colitis 1.45 2 2 6.1 0.00 1.0e+00 RNF123 STMN3
Blood Eosinophil Count 5.06 28 21 63.6 -0.68 2.4e-05 ACAD10 ACVR2A ADAM1A ADRA2B ALDH2 ARRB2 CD164 CERS5 CPEB4 DLG4 ERAP2 FIBP GIGYF1 GIMAP7 HAUS4 KAT8 MED19 MPHOSPH9 NAA25 OIP5-AS1 PITPNM2 PPTC7 RERE RP11-23P13.6 RP11-282O18.3 RP5-1029K10.2 SH2B3 TRAFD1
Blood Platelet Count 3.23 44 37 112.1 -0.19 2.0e-01 ACAD10 ADAM1A ADAMTS7 ALDH2 ANKFY1 C20orf160 C4orf3 CD164 CERS5 CLCN6 CPEB4 DCAF16 EDEM3 FIBP FLNB GMEB2 HELLS IRAK1BP1 KIF2A KRT8P33 LINC00461 MPHOSPH9 MTHFR NAA25 NELFCD NMT1 NOV NRBF2 PITPNM2 PPTC7 REEP3 RP11-282O18.3 RP11-436D10.3 RP11-462G12.1 RP11-91P24.7 RP5-1029K10.2 SETD8 SH2B3 SIPA1 SLC25A37 STMN3 STXBP5 TRAFD1 WNT2B
Blood Red Count 2.45 49 32 97.0 -0.65 1.5e-07 ABCB9 ACAD10 ACHE ACVR2A ADAM1A ADM ALDH2 ARNTL C20orf160 C4orf22 C6orf174 CCNE1 CD164 CLCN6 CPEB4 EIF2AK4 GIGYF1 GMEB2 HELLS HYI KAT8 LINC00461 LOC100129961 LSMD1 MAPKBP1 MPI MTHFR NAA25 NAT8 NDUFAF6 NELFCD NME6 NT5C2 PPTC7 REEP3 RNF123 RP11-23P13.4 RP11-23P13.7 RP11-375I20.6 RPAP1 SETD8 SH2B3 SLC9A3R2 STMN3 TMEM87B TRAFD1 ULK4 USP36 ZNF100
Blood White Count 3.13 33 24 72.7 -0.66 1.5e-05 ACAD10 ADAM1A ALDH2 ARRB2 C4orf3 CD164 CEP85L CERS5 DCAF16 ERAP2 FES FIBP FLNB HELLS LSMD1 NAA25 NRBF2 NT5C2 PLA2G4B PPTC7 REEP3 RERE RNF123 RP11-141J13.5 RP11-23P13.4 RP11-462G12.1 RP5-1029K10.2 SH2B3 SLC9A3R2 SRR TMEM133 TMEM87B TRAFD1
Heel T-Score 2.34 44 35 106.1 -0.11 4.7e-01 ABCB9 ACHE ACP2 ADRA2B C20orf160 C6orf174 CD164 CPEB4 CTNNB1 DCAF16 DLG4 FIBP FLNB GIGYF1 GLS JAG1 KAT8 KRT8P33 LSMD1 MPHOSPH9 NELFCD NMT1 NT5C2 PDE1A PITPNM2 RERE RNF123 RP11-141J13.5 RP11-282O18.3 RP11-462G12.1 RP11-7I15.3 RP11-91P24.7 SETD8 SF3A3 SIPA1 SLC9A3R2 SNTB2 SRR SRRT THSD4 TMEM133 TMEM87B TRIP6 WNT2B
BMI 2.35 40 20 60.6 -0.73 9.2e-08 ABCB9 ANKFY1 ARNTL ARRB2 C20orf160 C4orf22 CCNE1 CHP1 CPEB4 CTNNB1 DLG4 DYNC1I2 EDEM3 FIBP IFT57 KAT8 KIAA1199 LINC00461 LMOD1 LOC100129961 MANBA MLLT10 NCF1 NRBF2 NT5C2 PITPNM2 PPTC7 REEP3 RNF123 RP11-141J13.5 RP11-462G12.1 SLC25A37 SLC9A3R2 SRR STAG3L1 STMN3 STXBP5 TRAFD1 USP36 YBX2
Height 2.00 65 54 163.6 0.31 8.6e-03 ABCB9 ACAD10 ACHE ACP2 ADM AGPAT2 ALDH2 BCKDHB CCNE1 CD164 CEP152 CERS5 CHP1 CTNNB1 DCAF16 DYNC1I2 EDEM3 FES FRK GIGYF1 GIMAP7 HYI IGFBP3 JAG1 KAT8 KRT8P33 KTN1-AS1 MANBA MAPKBP1 MED19 MN1 MPHOSPH9 MSTN NMT1 NOV OAF OIP5-AS1 PDE1A PITPNM2 PPTC7 REEP3 RERE RNF123 RP11-282O18.3 RP11-375I20.6 RP11-436D10.3 RP11-462G12.1 RP11-7I15.3 RP11-91P24.7 RP5-1029K10.2 RSRC1 RYK SETD8 SF3A3 SH2B3 SLC24A3 SLC25A37 SLC9A3R2 SPON1 SRRT TMEM133 TNNT3 TRIP6 USP36 WNT2B
Waist Hip Ratio (WHR) 1.78 19 14 42.4 -0.30 2.0e-01 ADAM1A ADM BCKDHB C6orf174 CPEB4 DYNC1I2 MAPKBP1 MPHOSPH9 PLA2G4B RP11-23P13.4 RP11-23P13.6 RP11-23P13.7 RP11-282O18.3 RPAP1 SETD8 SIPA1 SWAP70 TCEA2 YBX2
Systolic Blood Pressure 9.32 95 81 245.5 -0.87 5.0e-33 AC006111.1 AC099850.1 ACAD10 ACP2 ADAM1A ADAMTS8 ADM AGT ALDH2 ARNTL ATP2B1 C1GALT1 C20orf160 C4orf22 C4orf3 C6orf174 CCDC148 CDH13 CERS5 CHP1 CLCN6 CPEB4 DCAF16 DLG4 EDEM3 EIF2AK4 ERAP2 FES FIBP GIMAP7 GLS GMEB2 HAUS4 HELLS HYI IGFBP3 IRAK1BP1 ITGB5 KIAA1199 KIF2A KRT8P33 LOC100129961 LSMD1 MED19 MPI MSTN MTHFR NAA25 NELFCD NME6 NMT1 NOC3L NOV NRBF2 NSUN6 NT5C2 OAF OIP5-AS1 PDE1A PLA2G4B PPTC7 REEP3 RERE RNF123 RP11-23P13.4 RP11-23P13.6 RP11-23P13.7 RP11-299J3.8 RP11-375I20.6 RP11-436D10.3 RP11-819C21.1 RP5-1029K10.2 RPAP1 RSRC1 RYK SH2B3 SIPA1 SLC16A1 SLC24A3 SLC25A37 SLC9A3R2 SRR STAG3L1 STXBP5 SWAP70 TCEA2 TENC1 TMEM133 TMEM87B TNNT3 TRAFD1 ULK4 USP36 WNT2B ZNF100
Smoking Status 1.35 8 3 9.1 -0.16 7.1e-01 ADAM1A BTBD1 CPEB4 FES KIAA1199 MLLT10 RERE SRR
Allergy or Eczema 2.17 15 8 24.2 -0.38 1.6e-01 ADAM1A CHP1 CLCN6 GMEB2 MPHOSPH9 MPI NMT1 NRBF2 OIP5-AS1 RERE RP11-282O18.3 RP5-1029K10.2 SRR STMN3 TRAFD1
Cardiovascular Disease 6.86 72 47 142.4 -0.98 1.6e-49 AC006111.1 ACAD10 ACP2 ADAM1A AGT ALDH2 ARNTL ATP2B1 C1GALT1 C20orf160 C4orf22 C6orf174 CCDC148 CERS5 CHP1 CLCN6 CPEB4 DCAF16 DLG4 FES FIBP GIMAP7 GMEB2 HELLS IRAK1BP1 ITGB5 KAT8 KIAA1199 KIF2A LMOD1 LSMD1 MANBA MPHOSPH9 MPI MTHFR NAA25 NCF1 NDUFAF6 NELFCD NME6 NMT1 NOC3L NRBF2 NSUN6 NT5C2 OAF OIP5-AS1 PDE1A PLA2G4B PPTC7 RERE RP11-23P13.4 RP11-261C10.5 RP11-436D10.3 RP11-462G12.1 RP11-819C21.1 RP5-1029K10.2 RPAP1 RYK SH2B3 SIPA1 STAG3 STAG3L1 SWAP70 TCEA2 TMEM133 TNNT3 TRAFD1 USP36 WNT2B ZKSCAN1 ZNF100
Hypothyroidism (self reported) 3.94 9 9 27.3 -0.55 5.1e-02 ACAD10 ADAM1A ALDH2 GIGYF1 NAA25 RERE SH2B3 SLC25A37 TRAFD1
Respiratory disease 1.49 6 3 9.1 -1.00 2.1e-05 CHP1 GMEB2 NMT1 RERE RP5-1029K10.2 STMN3
Type 2 Diabetes (T2D) 2.20 7 3 9.1 -0.86 1.2e-02 ANKFY1 C1GALT1 MPHOSPH9 PLA2G4B RNF123 RP11-23P13.4 SH2B3
Lung FEV1/FVC ratio 3.72 31 23 69.7 -0.26 1.4e-01 ADM ANKFY1 ATP2B1 C1GALT1 CD164 CPEB4 CTNNB1 GTPBP10 HAUS4 KRT8P33 LMOD1 MAPKBP1 MLLT10 NRBF2 PLA2G4B PPP1R3B RERE RP11-141J13.5 RP11-23P13.4 RP11-23P13.6 RP11-23P13.7 RP11-436D10.3 RP11-7I15.3 RP5-1029K10.2 RPAP1 SLC24A3 STAG3 THSD4 TMEM133 ULK4 ZKSCAN1
Lung FVC 1.58 22 11 33.3 0.28 2.1e-01 ADAMTS8 BTBD1 C1GALT1 CHP1 DCAF16 DLG4 GMEB2 JAG1 KAT8 LOC100129961 MAPKBP1 MLLT10 MPHOSPH9 NRBF2 PPTC7 RP11-282O18.3 RSRC1 SETD8 STMN3 THSD4 USP36 WNT2B
Neuroticism 1.47 6 2 6.1 0.04 9.4e-01 ADM ARNTL DYNC1I2 LINC00461 NT5C2 RERE
Chronotype (morning person) 1.42 4 0 0.0 -0.95 4.8e-02 ACAD10 ALDH2 NAA25 RHBDL3
Hair Pigment 0.42 24 20 60.6 0.11 5.9e-01 ACAD10 ACHE ACP2 ADM ALDH2 ATP2B1 BTBD1 C20orf160 C4orf22 FES GIGYF1 INTS4 LOC100129961 MPHOSPH9 PPP1R3B RERE RP11-282O18.3 RP11-7I15.3 RP11-91P24.7 SETD8 SH2B3 SIPA1 SRRT TRIP6
Tanning 0.24 4 3 9.1 0.42 5.8e-01 NRBF2 RP11-436D10.3 RP11-7I15.3 SH2B3
Hand grip strength (left) 1.45 6 4 12.1 0.03 9.6e-01 ACHE DCAF16 JAG1 LOC100129961 SLC9A3R2 SRRT
Number of treatments/medications taken 2.95 13 6 18.2 0.94 1.3e-06 ACAD10 ADAM1A C1GALT1 CHP1 DCAF16 FES KIAA1199 MANBA MLLT10 RNF123 SH2B3 TMEM133 TRAFD1
Sensitivity / hurt feelings 1.42 2 0 0.0 0.00 1.0e+00 AC099850.1 MSRA
Frequency of depressed mood in last 2 weeks 1.23 1 0 0.0 0.00 1.0e+00 RERE
Relative age of first facial hair 1.06 2 1 3.0 0.00 1.0e+00 C4orf22 REEP3
Ever had hysterectomy (womb removed) 1.27 1 0 0.0 0.00 1.0e+00 MLLT10
Systolic blood pressure, automated reading 8.11 83 57 172.7 0.91 9.8e-36 AC006111.1 AC099850.1 ACAD10 ACP2 ADAMTS8 ADM AGT ALDH2 ARNTL ATP2B1 C4orf22 C6orf174 CCDC148 CD164 CERS5 CHP1 CLCN6 CPEB4 DCAF16 DLG4 DYNC1I2 EDEM3 EIF2AK4 FES FIBP GIMAP7 GMEB2 HAUS4 HELLS HYI IRAK1BP1 ITGB5 KIAA1199 KIF2A LOC100129961 MED19 MPI MSRA MSTN MTHFR NAA25 NCF1 NEIL2 NELFCD NME6 NMT1 NOC3L NOV NRBF2 NSUN6 NT5C2 OAF OIP5-AS1 PLA2G4B PPP1R3B PPTC7 RERE RNF123 RP11-23P13.4 RP11-299J3.8 RP11-375I20.6 RP11-436D10.3 RP11-819C21.1 RP5-1029K10.2 RSRC1 SH2B3 SIPA1 SLC16A1 SLC9A3R2 SRR STAG3L1 STMN3 STXBP5 SWAP70 TCEA2 TENC1 TMEM133 TMEM87B TNNT3 ULK4 USP36 WNT2B YBX2
Angina 1.69 2 2 6.1 0.00 1.0e+00 ADAMTS7 FES
Vitamin and mineral supplements 1.27 1 0 0.0 0.00 1.0e+00 REEP3
Medication: Metformin 1.81 3 0 0.0 0.00 1.0e+00 MANBA MPHOSPH9 RPAP1
Pack years adult smoking proportion 1.46 1 1 3.0 0.00 1.0e+00 ADAMTS7
Impedance of leg (right) 2.07 32 24 72.7 -0.08 6.7e-01 ADM ADRA2B C4orf3 CCNE1 CERS5 DYNC1I2 FES GIMAP7 GNAO1 HELLS IGFBP3 KIAA1199 KRT8P33 LINC00461 LMOD1 MSRA NCF1 NELFCD NOC3L NT5C2 PLA2G4B PPP1R3B RNF123 RP11-23P13.4 RP11-23P13.7 RP11-462G12.1 RP5-1029K10.2 SRR STAG3L1 SWAP70 TMEM133 WNT2B
Leg fat-free mass (left) 2.19 33 24 72.7 0.27 1.3e-01 ACAD10 ADM BCKDHB CCNE1 CD164 CPEB4 CTNNB1 DCAF16 DYNC1I2 FIBP HELLS KAT8 KIAA1199 KRT8P33 LINC00461 LMOD1 MLLT10 MPHOSPH9 MSRA NOV NT5C2 PDE1A PPTC7 RNF123 RP11-282O18.3 RP11-436D10.3 RP11-462G12.1 SF3A3 SLC25A37 SLC9A3R2 STAG3L1 TRAFD1 USP36
Trunk fat percentage 2.31 24 14 42.4 0.80 2.3e-06 ADM ARNTL CCDC148 CCNE1 CHP1 CTNNB1 DLG4 EDEM3 KAT8 LINC00461 LMOD1 LOC100129961 MLLT10 NCF1 NOC3L OIP5-AS1 PITPNM2 RERE RNF123 RP11-462G12.1 SLC25A37 STAG3L1 WNT2B YBX2
Hand grip strength (right) 1.65 11 5 15.2 0.08 8.1e-01 ACHE DCAF16 EDEM3 GIGYF1 JAG1 LOC100129961 MLLT10 SLC9A3R2 SRRT TRIP6 WNT2B
Current tobacco smoking 1.70 3 0 0.0 0.00 1.0e+00 ALDH2 MSRA STMN3
Maternal smoking around birth 1.54 3 0 0.0 0.00 1.0e+00 C20orf160 MLLT10 RNF123
Fed-up feelings 1.92 8 3 9.1 -0.58 1.3e-01 ACAD10 ALDH2 ARNTL LINC00461 MPHOSPH9 MSRA RNF123 SH2B3
Taking other prescription medications 1.88 4 2 6.1 0.98 2.0e-02 ACAD10 ADAM1A RNF123 SH2B3
Age when periods started (menarche) 1.51 7 3 9.1 -0.80 3.0e-02 ARNTL NCF1 NMT1 RP11-7I15.3 STAG3L1 STXBP5 ZKSCAN1
Bilateral oophorectomy (both ovaries removed) 1.32 1 0 0.0 0.00 1.0e+00 MLLT10
Heel bone mineral density (BMD) T-score, automated (left) 2.06 9 7 21.2 0.33 3.9e-01 ACP2 C6orf174 JAG1 LSMD1 MSRA PPP1R3B RERE RNF123 WNT2B
Qualifications: CSEs or equivalent 1.12 1 0 0.0 0.00 1.0e+00 RNF123
High blood pressure 7.25 74 38 115.2 0.97 8.1e-50 AC006111.1 ACAD10 ACP2 ADAM1A ADM AGT ALDH2 ARNTL ATP2B1 C1GALT1 C20orf160 C4orf22 C6orf174 CCDC148 CCNE1 CERS5 CHP1 CLCN6 DCAF16 DLG4 EDEM3 FES FIBP GIMAP7 GMEB2 HELLS IRAK1BP1 ITGB5 KAT8 KIAA1199 KIF2A LMOD1 LSMD1 MANBA MLLT10 MPI MSRA MTHFR NAA25 NCF1 NDUFAF6 NEIL2 NELFCD NME6 NMT1 NOC3L NRBF2 NSUN6 NT5C2 OIP5-AS1 PDE1A PLA2G4B PPTC7 REEP3 RERE RP11-261C10.5 RP11-436D10.3 RP5-1029K10.2 RPAP1 RSRC1 RYK SH2B3 SIPA1 SLC25A37 SRR STAG3 STAG3L1 SWAP70 TCEA2 TMEM133 TNNT3 TRAFD1 WNT2B ZKSCAN1
Hayfever, allergic rhinitis or eczema 1.97 8 4 12.1 0.66 7.2e-02 ADAM1A CHP1 MPHOSPH9 PITPNM2 RERE RP11-282O18.3 STMN3 TRAFD1
Multivitamins +/- minerals 1.25 1 1 3.0 0.00 1.0e+00 REEP3
Stomach or abdominal pain in last month 1.41 1 0 0.0 0.00 1.0e+00 GIGYF1
Supplements: Glucosamine 1.67 2 1 3.0 0.00 1.0e+00 NRBF2 REEP3
Medication: Atenolol 3.02 5 3 9.1 0.97 7.5e-03 ACAD10 FES SH2B3 TMEM133 TRAFD1
Medication: Levothyroxine sodium 3.61 8 7 21.2 0.71 2.1e-02 ACAD10 ADAM1A ALDH2 GIGYF1 MSRA NAA25 SH2B3 TRAFD1
Sitting height 2.16 29 20 60.6 -0.25 1.8e-01 ABCB9 ADM AGPAT2 BCKDHB C20orf160 CCNE1 CD164 CERS5 CHP1 CTNNB1 DCAF16 FLNB JAG1 KIAA1199 KRT8P33 MN1 MPHOSPH9 NOV OIP5-AS1 PITPNM2 PPP1R3B RP11-282O18.3 RP11-375I20.6 RP11-436D10.3 RP5-1029K10.2 RSRC1 SETD8 SF3A3 SLC9A3R2
High blood pressure (mother) 3.22 5 2 6.1 0.99 6.8e-04 AGT C6orf174 FES ITGB5 TNNT3
Body mass index (BMI) 2.53 27 14 42.4 0.86 8.7e-09 ABCB9 ARNTL CCDC148 CCNE1 DYNC1I2 EDEM3 FIBP IFT57 KAT8 KIAA1199 LINC00461 LMOD1 LOC100129961 MLLT10 MSRA NCF1 PITPNM2 PPP1R3B PPTC7 REEP3 RERE RNF123 RP11-462G12.1 SLC25A37 SLC9A3R2 SRR STAG3L1
Impedance of leg (left) 2.04 31 24 72.7 -0.08 6.7e-01 ADM ADRA2B C4orf3 CCNE1 CERS5 FES GIMAP7 GNAO1 HELLS IGFBP3 KIAA1199 KRT8P33 LINC00461 LMOD1 MSRA NELFCD NOC3L NT5C2 PLA2G4B PPP1R3B RNF123 RP11-23P13.4 RP11-23P13.7 RP11-462G12.1 RP5-1029K10.2 SRR STAG3L1 SWAP70 TMEM133 ULK4 WNT2B
Leg predicted mass (left) 2.18 35 24 72.7 0.24 1.7e-01 ACAD10 ADM BCKDHB CCNE1 CD164 CPEB4 CTNNB1 DCAF16 DYNC1I2 FIBP HELLS KAT8 KIAA1199 KRT8P33 LINC00461 LMOD1 MLLT10 MPHOSPH9 MSRA NOV NT5C2 PDE1A PLA2G4B PPTC7 RNF123 RP11-282O18.3 RP11-436D10.3 RP11-462G12.1 SF3A3 SLC25A37 SLC9A3R2 STAG3L1 TRAFD1 ULK4 USP36
Trunk fat mass 2.33 25 17 51.5 0.74 2.2e-05 ARNTL CCNE1 CTNNB1 DLG4 DYNC1I2 EDEM3 FIBP KAT8 KIAA1199 LINC00461 LMOD1 LOC100129961 MLLT10 MSRA NCF1 PITPNM2 PPTC7 RERE RNF123 RP11-462G12.1 SLC25A37 SLC9A3R2 STAG3L1 USP36 WNT2B
Waist circumference 2.40 22 14 42.4 0.84 1.0e-06 ARNTL CCDC148 CCNE1 CTNNB1 DLG4 FIBP IFT57 KAT8 KIAA1199 LINC00461 LMOD1 MLLT10 NCF1 NRBF2 PPTC7 RNF123 RP11-462G12.1 RPAP1 SLC25A37 SLC9A3R2 STAG3L1 USP36
Number of incorrect matches in round 1.08 2 0 0.0 0.00 1.0e+00 KAT8 LOC100129961
Past tobacco smoking 1.57 6 0 0.0 -0.73 1.0e-01 ACAD10 ADAM1A ALDH2 MLLT10 SH2B3 SRR
Nervous feelings 1.34 5 2 6.1 -0.68 2.0e-01 ADM ARNTL KAT8 MSRA PPP1R3B
Hair/balding pattern: Pattern 2 1.16 2 1 3.0 0.00 1.0e+00 C4orf22 NMT1
Had menopause 1.37 1 0 0.0 0.00 1.0e+00 CHP1
Forced vital capacity (FVC) 1.86 18 9 27.3 0.07 7.8e-01 ACHE BCKDHB CTNNB1 DCAF16 FLNB GMEB2 JAG1 LOC100129961 MLLT10 MN1 NOV RP11-91P24.7 RSRC1 SRRT STMN3 TRIP6 U91328.21 WNT2B
Heel bone mineral density (BMD) T-score, automated (right) 1.97 9 6 18.2 0.32 4.1e-01 ACP2 C6orf174 DCAF16 LSMD1 MSRA PPP1R3B RERE RNF123 WNT2B
Qualifications: None of the above 1.70 6 4 12.1 0.93 6.8e-04 IRAK1BP1 MPHOSPH9 RNF123 RP11-261C10.5 RP11-282O18.3 SETD8
Mouth/teeth dental problems 1.23 2 0 0.0 0.00 1.0e+00 NCF1 RP11-261C10.5
Heart attack 1.86 1 0 0.0 0.00 1.0e+00 FES
Allergy 1.98 11 6 18.2 -0.87 5.2e-04 CHP1 GMEB2 MPHOSPH9 NMT1 OIP5-AS1 RERE RP11-282O18.3 RP5-1029K10.2 SETD8 STMN3 TRAFD1
Diabetes (self-reported) 1.79 3 1 3.0 0.00 1.0e+00 C1GALT1 MPHOSPH9 RNF123
Medication: Ramipril 2.49 3 1 3.0 0.00 1.0e+00 ADAM1A MPI TMEM133
Medication: Simvastatin 1.91 1 0 0.0 0.00 1.0e+00 FES
Fluid intelligence score 1.60 8 2 6.1 -0.98 2.5e-05 DCAF16 LMOD1 MPHOSPH9 NAT8 RNF123 RP11-282O18.3 SETD8 U91328.21
Illnesses of siblings 2.65 3 1 3.0 0.00 1.0e+00 ACAD10 FES SH2B3
Neuroticism score 1.75 7 3 9.1 -0.59 1.6e-01 ADM ARNTL LINC00461 MPHOSPH9 MSRA PPP1R3B RERE
Weight 2.34 31 23 69.7 0.35 5.4e-02 ACAD10 BCKDHB CCNE1 CD164 CTNNB1 DCAF16 DLG4 DYNC1I2 FIBP IFT57 KAT8 KIAA1199 KRT8P33 LINC00461 LMOD1 MLLT10 MSRA NCF1 PPTC7 RNF123 RP11-282O18.3 RP11-436D10.3 RP11-462G12.1 SF3A3 SH2B3 SLC25A37 SLC9A3R2 STAG3L1 TRAFD1 USP36 WNT2B
Impedance of arm (right) 1.80 24 13 39.4 -0.38 6.8e-02 ADM CERS5 FIBP HELLS IGFBP3 KIAA1199 KTN1-AS1 LMOD1 MANBA MLLT10 MSRA NOC3L NRBF2 PDE1A PPP1R3B PPTC7 RNF123 RP11-462G12.1 RP11-7I15.3 RP5-1029K10.2 SLC9A3R2 STAG3L1 TRAFD1 WNT2B
Arm fat percentage (right) 2.38 27 18 54.5 0.91 2.4e-11 ABCB9 ADM ARNTL CCDC148 CCNE1 CHP1 DCAF16 DLG4 EDEM3 IFT57 KAT8 LINC00461 LMOD1 LOC100129961 MLLT10 MSRA NCF1 OIP5-AS1 PITPNM2 RERE RNF123 RP11-462G12.1 SLC25A37 SRR STAG3L1 STXBP5 YBX2
Trunk fat-free mass 2.22 35 26 78.8 -0.21 2.1e-01 ACAD10 ADM ALDH2 BCKDHB CCNE1 CD164 CTNNB1 DCAF16 DYNC1I2 HELLS KAT8 KIAA1199 KRT8P33 LMOD1 MN1 MPHOSPH9 NMT1 NOV OIP5-AS1 PDE1A PPTC7 RNF123 RP11-282O18.3 RP11-375I20.6 RP11-436D10.3 RP11-462G12.1 SETD8 SF3A3 SH2B3 SLC25A37 SLC9A3R2 TMEM133 TRAFD1 ULK4 USP36
Hip circumference 2.36 33 18 54.5 0.37 2.9e-02 ACAD10 ALDH2 CCNE1 CLCN6 CPEB4 CTNNB1 DCAF16 DLG4 DYNC1I2 FIBP IFT57 IRAK1BP1 KAT8 KIAA1199 LINC00461 LMOD1 LOC100129961 MLLT10 MSRA NCF1 PPP1R3B PPTC7 RNF123 RP11-282O18.3 RP11-462G12.1 SH2B3 SLC25A37 SLC9A3R2 STAG3L1 STMN3 TRAFD1 USP36 YBX2
Alcohol intake versus 10 years previously 1.28 1 1 3.0 0.00 1.0e+00 RNF123
Father's age at death 2.44 3 1 3.0 0.00 1.0e+00 FES MPHOSPH9 SH2B3
Worrier / anxious feelings 1.64 4 1 3.0 -0.85 1.5e-01 ARNTL MSRA PPP1R3B RP11-462G12.1
Frequency of tiredness / lethargy in last 2 weeks 1.51 3 0 0.0 0.00 1.0e+00 ALDH2 LMOD1 RERE
Hair/balding pattern: Pattern 3 1.45 1 1 3.0 0.00 1.0e+00 C4orf22
Forced expiratory volume in 1-second (FEV1) 1.91 15 9 27.3 -0.07 8.1e-01 BCKDHB C1GALT1 CD164 CTNNB1 DCAF16 FLNB JAG1 LOC100129961 MN1 MSRA NRBF2 RSRC1 THSD4 TMEM133 U91328.21
Pulse rate 3.95 9 7 21.2 0.97 4.2e-07 AC005517.3 ACHE CEP85L CTNNB1 GIGYF1 SPON1 SRRT STAG3 TRIP6
Qualifications: A levels/AS levels or equivalent 2.07 9 5 15.2 -0.95 2.2e-05 ABCB9 DCAF16 MPHOSPH9 MSRA RNF123 RP11-261C10.5 RP11-282O18.3 SETD8 STAG3L1
Mouth/teeth dental problems: Dentures 1.27 2 0 0.0 0.00 1.0e+00 MSRA RNF123
Asthma 1.48 5 2 6.1 0.63 2.6e-01 NMT1 RERE RP5-1029K10.2 STMN3 U91328.21
Medication: Ibuprofen (e.g. Nurofen) 1.57 1 0 0.0 0.00 1.0e+00 U91328.21
Medication: Cholesterol lowering 2.04 3 2 6.1 0.00 1.0e+00 CHP1 FES TMEM133
Depression (self-reported) 1.07 1 0 0.0 0.00 1.0e+00 RERE
Lung cancer (father) 1.28 1 0 0.0 0.00 1.0e+00 ADAMTS7
Illnesses of mother 2.05 1 1 3.0 0.00 1.0e+00 FES
Forced expiratory volume in 1-second (FEV1), Best measure 1.92 15 8 24.2 -0.11 6.9e-01 BCKDHB C1GALT1 CTNNB1 DCAF16 FLNB JAG1 KAT8 KRT8P33 LOC100129961 MN1 MSRA NRBF2 RSRC1 THSD4 U91328.21
Pulse wave Arterial Stiffness index 1.66 1 1 3.0 0.00 1.0e+00 ADAM1A
Impedance of arm (left) 1.77 27 15 45.5 -0.26 1.9e-01 ACAD10 ADM CERS5 FIBP HELLS IGFBP3 KIAA1199 KTN1-AS1 LMOD1 MANBA MLLT10 MSRA NOC3L NRBF2 PDE1A PPP1R3B PPTC7 RNF123 RP11-462G12.1 RP11-7I15.3 RP5-1029K10.2 SH2B3 SLC9A3R2 STAG3L1 TNNT3 TRAFD1 WNT2B
Arm fat mass (right) 2.42 28 13 39.4 0.85 8.5e-09 ARNTL CCNE1 CTNNB1 DLG4 DYNC1I2 EDEM3 FIBP IFT57 KAT8 KIAA1199 LINC00461 LMOD1 LOC100129961 MLLT10 MSRA NCF1 PITPNM2 PPP1R3B PPTC7 RERE RNF123 RP11-462G12.1 SLC25A37 SLC9A3R2 SRR STAG3L1 STXBP5 USP36
Trunk predicted mass 2.22 34 25 75.8 -0.22 2.0e-01 ACAD10 ADM ALDH2 BCKDHB CCNE1 CD164 CTNNB1 DCAF16 DYNC1I2 HELLS KAT8 KIAA1199 KRT8P33 LMOD1 MN1 MPHOSPH9 NMT1 NOV OIP5-AS1 PDE1A PPTC7 RNF123 RP11-282O18.3 RP11-375I20.6 RP11-436D10.3 RP11-462G12.1 SETD8 SF3A3 SH2B3 SLC25A37 SLC9A3R2 TRAFD1 ULK4 USP36
Standing height 1.93 48 31 93.9 -0.33 2.1e-02 ABCB9 ACAD10 ACHE ACP2 ACVR2A ADM AGPAT2 ALDH2 BCKDHB CCNE1 CD164 CEP152 CERS5 CHP1 CTNNB1 DCAF16 DYNC1I2 EDEM3 FRK IGFBP3 JAG1 KRT8P33 MN1 MPHOSPH9 MSRA NMT1 NOV OAF OIP5-AS1 PDE1A PITPNM2 REEP3 RP11-282O18.3 RP11-375I20.6 RP11-436D10.3 RP11-462G12.1 RP11-91P24.7 RP5-1029K10.2 RYK SETD8 SF3A3 SH2B3 SLC25A37 SLC9A3R2 SRRT TRIP6 USP36 WNT2B
Tense / 'highly strung' 1.48 4 2 6.1 -0.60 4.0e-01 KAT8 MSRA NT5C2 RERE
Seen doctor (GP) for nerves, anxiety, tension or depression 1.35 1 0 0.0 0.00 1.0e+00 U91328.21
Hair/balding pattern: Pattern 4 1.55 5 3 9.1 0.49 4.0e-01 C4orf22 CERS5 CTNNB1 RERE SRR
Birth weight of first child 2.39 11 4 12.1 -0.89 1.2e-04 ACAD10 ALDH2 CLCN6 DCAF16 DLG4 FES MTHFR SH2B3 SLC25A37 STAG3L1 TRAFD1
Peak expiratory flow (PEF) 1.64 8 4 12.1 -0.24 5.6e-01 BTBD1 C1GALT1 DCAF16 DLG4 FLNB MSRA SLC9A3R2 THSD4
Qualifications: O levels/GCSEs or equivalent 1.64 4 2 6.1 -0.98 1.8e-02 MPHOSPH9 RNF123 RP11-282O18.3 SETD8
Medication: Paracetamol 1.70 3 2 6.1 0.00 1.0e+00 MLLT10 RP11-261C10.5 U91328.21
Headache pain in last month 1.86 5 2 6.1 -0.19 7.6e-01 MED19 PPP1R3B RP11-261C10.5 SLC24A3 U91328.21
Medication for cholesterol, blood pressure or diabetes 3.74 15 5 15.2 -0.96 8.8e-09 ATP2B1 C4orf22 CHP1 CLCN6 FES KIAA1199 MPI MTHFR NME6 RNF123 SH2B3 STAG3 TMEM133 WNT2B ZKSCAN1
Gout (self-reported) 1.42 1 0 0.0 0.00 1.0e+00 SH2B3
Hypothyroidism/myxoedema (self-reported) 3.65 10 8 24.2 0.39 1.7e-01 ACAD10 ADAM1A ALDH2 GIGYF1 MSRA NAA25 PPP1R3B RERE SH2B3 TRAFD1
Medication: Amlodipine 3.29 9 6 18.2 0.87 2.2e-03 AC099850.1 C6orf174 CLCN6 FES KIAA1199 MTHFR TMEM133 TNNT3 WNT2B
Birth weight 2.54 10 7 21.2 -0.60 6.4e-02 ACAD10 ADAM1A ALDH2 DCAF16 DLG4 FES SH2B3 SRR TMEM87B TRAFD1
High blood pressure (siblings) 3.14 8 2 6.1 0.97 7.4e-05 ACP2 CLCN6 FES KAT8 NRBF2 SH2B3 TMEM133 TNNT3
Forced vital capacity (FVC), Best measure 1.76 19 7 21.2 -0.14 5.8e-01 ACHE ACP2 BCKDHB CTNNB1 DCAF16 FLNB GMEB2 JAG1 LOC100129961 MLLT10 MN1 NOV RNF123 RSRC1 SPON1 SRRT STMN3 TRIP6 U91328.21
Body fat percentage 2.52 31 16 48.5 0.84 3.4e-09 ABCB9 ADM ARNTL CCDC148 CCNE1 CHP1 DCAF16 DLG4 EDEM3 FIBP HELLS KAT8 LINC00461 LMOD1 LOC100129961 MLLT10 MSRA NCF1 NOC3L OIP5-AS1 PITPNM2 RERE RNF123 RP11-462G12.1 SLC25A37 SLC9A3R2 STAG3L1 STMN3 STXBP5 WNT2B YBX2
Leg fat percentage (right) 2.86 38 18 54.5 0.84 5.8e-11 ABCB9 ADM ARNTL CCDC148 CCNE1 CHP1 DCAF16 DLG4 EDEM3 FIBP HELLS KAT8 LINC00461 LMOD1 LOC100129961 MLLT10 MPHOSPH9 MSRA NCF1 NDUFAF6 NMT1 NOC3L OIP5-AS1 PITPNM2 PPP1R3B PPTC7 REEP3 RERE RNF123 RP11-141J13.5 RP11-462G12.1 SLC25A37 SLC9A3R2 STAG3L1 STMN3 STXBP5 WNT2B YBX2
Arm fat-free mass (right) 2.31 35 27 81.8 0.02 9.0e-01 ACAD10 ADM ALDH2 BCKDHB CCNE1 CD164 CTNNB1 DCAF16 DYNC1I2 FIBP HELLS KAT8 KIAA1199 KRT8P33 LINC00461 LMOD1 MLLT10 MPHOSPH9 MSRA NMT1 NOV PDE1A PPTC7 RNF123 RP11-282O18.3 RP11-375I20.6 RP11-462G12.1 SETD8 SF3A3 SH2B3 SLC25A37 SLC9A3R2 STAG3L1 TRAFD1 USP36
Comparative body size at age 10 1.55 10 3 9.1 0.44 2.1e-01 ADRA2B CERS5 KAT8 MSRA NME6 PPP1R3B RP11-462G12.1 SRR U91328.21 WNT2B
Worry too long after embarrassment 1.62 3 2 6.1 0.00 1.0e+00 ARNTL LINC00461 MSRA
Wheeze or whistling in the chest in last year 1.58 5 2 6.1 0.99 1.6e-03 GMEB2 NMT1 RERE RNF123 STMN3
Age at first live birth 1.65 2 1 3.0 0.00 1.0e+00 DCAF16 RNF123
Pulse wave peak to peak time 1.59 1 1 3.0 0.00 1.0e+00 ADAM1A
Health satisfaction 1.23 1 1 3.0 0.00 1.0e+00 LMOD1
Shortness of breath walking on level ground 1.07 2 0 0.0 0.00 1.0e+00 LMOD1 USP36
Qualifications: College or University degree 1.86 13 7 21.2 -0.82 2.9e-04 ABCB9 CCDC148 DCAF16 EDEM3 HAUS4 LINC00461 LMOD1 MLLT10 MPHOSPH9 RNF123 RP11-261C10.5 RP11-282O18.3 SETD8
Medication for pain relief, constipation, heartburn 2.02 6 1 3.0 -0.96 2.4e-03 C20orf160 KIAA1199 LMOD1 MPHOSPH9 RP11-261C10.5 U91328.21
Medication: Blood pressure 4.59 20 13 39.4 0.97 1.3e-12 ACAD10 ACP2 ADAM1A ATP2B1 C20orf160 C4orf22 CLCN6 DCAF16 DLG4 FES KIAA1199 MANBA MPI MTHFR NME6 NOC3L SH2B3 TMEM133 TNNT3 WNT2B
Angina (self-reported) 1.64 2 2 6.1 0.00 1.0e+00 ADAMTS7 FES
Migraine (self-reported) 1.61 2 0 0.0 0.00 1.0e+00 NT5C2 SLC24A3
Mean time to correctly identify matches 2.00 5 4 12.1 0.97 1.2e-03 ACAD10 ALDH2 DLG4 NAA25 SH2B3
Heart disease (mother) 1.72 1 0 0.0 0.00 1.0e+00 ADAMTS7
Whole body fat mass 2.48 29 20 60.6 0.78 6.0e-07 ANKFY1 ARNTL CCDC148 CCNE1 CTNNB1 DLG4 DYNC1I2 EDEM3 FIBP KAT8 KIAA1199 LINC00461 LMOD1 LOC100129961 MLLT10 MSRA NCF1 PITPNM2 PPTC7 RERE RNF123 RP11-462G12.1 SLC25A37 SLC9A3R2 STAG3L1 STMN3 STXBP5 USP36 WNT2B
Leg fat mass (right) 2.75 30 16 48.5 0.79 2.1e-07 ANKFY1 ARNTL CCNE1 CTNNB1 DYNC1I2 EDEM3 FIBP IFT57 KAT8 KIAA1199 LINC00461 LMOD1 LOC100129961 MLLT10 MSRA NCF1 PITPNM2 PPP1R3B PPTC7 RERE RNF123 RP11-462G12.1 SLC25A37 SLC9A3R2 STAG3L1 STMN3 STXBP5 USP36 WNT2B YBX2
Arm predicted mass (right) 2.33 34 27 81.8 0.02 9.3e-01 ACAD10 ADM ALDH2 BCKDHB CCNE1 CD164 CTNNB1 DCAF16 DYNC1I2 FIBP HELLS KAT8 KIAA1199 KRT8P33 LINC00461 LMOD1 MLLT10 MPHOSPH9 MSRA NOV OIP5-AS1 PDE1A PPTC7 RNF123 RP11-282O18.3 RP11-462G12.1 SETD8 SF3A3 SH2B3 SLC25A37 SLC9A3R2 STAG3L1 TRAFD1 USP36
Pulse rate, automated reading 5.67 25 14 42.4 0.78 1.7e-06 AC005517.3 ACHE ACP2 ADRA2B BTBD1 CASP7 CEP85L CTNNB1 GIGYF1 KAT8 KRT8P33 LINC00461 LMOD1 LOC100129961 MSTN PPTC7 RNF123 RP11-299J3.8 RP11-7I15.3 SPON1 SRRT STAG3 STAG3L1 TRIP6 ZKSCAN1
Alcohol intake frequency. 1.44 6 1 3.0 0.99 8.3e-05 FIBP KAT8 MPHOSPH9 RNF123 RP11-282O18.3 SETD8
Comparative height size at age 10 1.96 25 14 42.4 -0.48 1.0e-02 ABCB9 ACAD10 ALDH2 BCKDHB CD164 CEP152 CTNNB1 DCAF16 FRK IGFBP3 KIAA1199 MN1 MPHOSPH9 NOV PPTC7 RP11-282O18.3 RP11-462G12.1 SETD8 SH2B3 SLC25A37 SLC9A3R2 TRAFD1 U91328.21 USP36 WNT2B
Number of full sisters 1.26 1 0 0.0 0.00 1.0e+00 NRBF2
Suffer from 'nerves' 1.27 3 0 0.0 0.00 1.0e+00 KTN1-AS1 MSRA RERE
Overall health rating 1.87 7 5 15.2 0.98 1.2e-04 KAT8 LMOD1 MLLT10 MSRA NCF1 RNF123 RP11-261C10.5
Chest pain or discomfort 1.18 1 0 0.0 0.00 1.0e+00 USP36
Age at last live birth 1.43 1 1 3.0 0.00 1.0e+00 RNF123
Leg pain on walking 1.33 1 1 3.0 0.00 1.0e+00 RNF123
Qualifications: NVQ or HND or HNC or equivalent 1.74 1 0 0.0 0.00 1.0e+00 RNF123
Medication: Aspirin 1.85 1 1 3.0 0.00 1.0e+00 FES
Knee pain experienced in last month 1.51 1 0 0.0 0.00 1.0e+00 RP11-261C10.5
Hypertension (Self-reported) 7.10 68 39 118.2 0.97 5.6e-46 AC006111.1 ACAD10 ACP2 ADAM1A ADM AGT ALDH2 ARNTL ATP2B1 C1GALT1 C20orf160 C4orf22 C6orf174 CCDC148 CERS5 CHP1 CLCN6 DCAF16 DLG4 EDEM3 FES FIBP GMEB2 HELLS IRAK1BP1 ITGB5 KAT8 KIAA1199 KIF2A LMOD1 LSMD1 MANBA MLLT10 MPI MSRA MTHFR NAA25 NCF1 NDUFAF6 NEIL2 NELFCD NME6 NMT1 NOC3L NRBF2 NSUN6 NT5C2 OIP5-AS1 PDE1A PLA2G4B PPTC7 RERE RP11-261C10.5 RP11-436D10.3 RPAP1 RSRC1 SH2B3 SLC25A37 SRR STAG3 STAG3L1 SWAP70 TCEA2 TMEM133 TNNT3 TRAFD1 WNT2B ZKSCAN1
Illnesses of father: Heart disease 2.02 3 3 9.1 0.00 1.0e+00 ADAMTS7 CDH13 FES
Smoking status: Previous 1.60 3 0 0.0 0.00 1.0e+00 ACAD10 ALDH2 SH2B3
Forced expiratory volume in 1-second (FEV1), predicted 1.54 3 1 3.0 0.00 1.0e+00 DCAF16 DYNC1I2 RP11-375I20.6
Whole body fat-free mass 2.24 39 29 87.9 -0.03 8.3e-01 ACAD10 ADM ALDH2 BCKDHB CCNE1 CD164 CPEB4 CTNNB1 DCAF16 DYNC1I2 FIBP HELLS KAT8 KIAA1199 KRT8P33 LINC00461 LMOD1 MN1 MPHOSPH9 MSRA NOV NT5C2 OIP5-AS1 PDE1A PLA2G4B PPTC7 RNF123 RP11-282O18.3 RP11-436D10.3 RP11-462G12.1 SETD8 SF3A3 SH2B3 SLC25A37 SLC9A3R2 STAG3L1 TRAFD1 ULK4 USP36
Leg fat-free mass (right) 2.19 35 26 78.8 0.10 5.8e-01 ACAD10 ADM BCKDHB CCNE1 CD164 CPEB4 CTNNB1 DCAF16 DYNC1I2 FIBP HELLS KAT8 KIAA1199 KRT8P33 LINC00461 LMOD1 MPHOSPH9 MSRA NOV NT5C2 PDE1A PLA2G4B PPTC7 RNF123 RP11-282O18.3 RP11-436D10.3 RP11-462G12.1 SETD8 SF3A3 SH2B3 SLC25A37 SLC9A3R2 STAG3L1 TRAFD1 USP36
Arm fat percentage (left) 2.37 27 18 54.5 0.91 2.6e-11 ABCB9 ADM ARNTL CCDC148 CCNE1 CHP1 DCAF16 DLG4 EDEM3 IFT57 KAT8 LINC00461 LMOD1 LOC100129961 MLLT10 MSRA NCF1 OIP5-AS1 PITPNM2 RERE RNF123 RP11-462G12.1 SLC25A37 SRR STAG3L1 STXBP5 YBX2
Average weekly red wine intake 1.63 3 0 0.0 0.00 1.0e+00 MPI RP11-282O18.3 SETD8
Mood swings 1.53 3 2 6.1 0.00 1.0e+00 ACP2 MSRA RNF123
Loneliness, isolation 1.67 1 0 0.0 0.00 1.0e+00 RERE
Long-standing illness, disability or infirmity 1.83 1 0 0.0 0.00 1.0e+00 CHP1
Ever had bowel cancer screening 1.07 1 0 0.0 0.00 1.0e+00 RNF123
Diabetes diagnosed by doctor 1.96 3 0 0.0 0.00 1.0e+00 MPHOSPH9 PLA2G4B RNF123
Qualifications: nursing, teaching 1.72 5 3 9.1 -0.99 9.7e-04 LMOD1 MPHOSPH9 RNF123 RP11-282O18.3 SETD8
Eye problems/disorders: Cataract 1.10 1 1 3.0 0.00 1.0e+00 SLC24A3
Mouth/teeth dental problems: Mouth ulcers 1.20 1 0 0.0 0.00 1.0e+00 PREX1
Medication for cholesterol 3.54 10 3 9.1 -0.95 5.1e-06 ACAD10 AGT C4orf22 C6orf174 MANBA SH2B3 TMEM133 TNNT3 TRAFD1 WNT2B
Mineral and other dietary supplements 1.53 3 1 3.0 0.00 1.0e+00 NMT1 NRBF2 REEP3
Asthma (self-reported) 1.48 5 2 6.1 0.65 2.4e-01 NMT1 RERE RP5-1029K10.2 STMN3 U91328.21
Medication: Aspirin 1.84 1 1 3.0 0.00 1.0e+00 FES
Medication: Gliclazide 1.61 1 0 0.0 0.00 1.0e+00 RP11-23P13.7
Illnesses of father: None of the above (group 1) 2.20 2 1 3.0 0.00 1.0e+00 FES SH2B3
Smoking status: Current 1.73 3 0 0.0 0.00 1.0e+00 ALDH2 BTBD1 MSRA
Forced expiratory volume in 1-second (FEV1), predicted percentage 1.81 6 3 9.1 0.64 1.7e-01 ANKFY1 JAG1 KAT8 NRBF2 THSD4 U91328.21
Whole body water mass 2.25 39 29 87.9 -0.04 7.9e-01 ACAD10 ADM ALDH2 BCKDHB CCNE1 CD164 CPEB4 CTNNB1 DCAF16 DYNC1I2 FIBP HELLS KAT8 KIAA1199 KRT8P33 LINC00461 LMOD1 MPHOSPH9 MSRA NMT1 NOV NT5C2 OIP5-AS1 PDE1A PLA2G4B PPTC7 RNF123 RP11-282O18.3 RP11-436D10.3 RP11-462G12.1 SETD8 SF3A3 SH2B3 SLC25A37 SLC9A3R2 STAG3L1 TRAFD1 ULK4 USP36
Leg predicted mass (right) 2.19 34 26 78.8 0.16 3.7e-01 ACAD10 ADM BCKDHB CCNE1 CD164 CPEB4 CTNNB1 DCAF16 DYNC1I2 FIBP HELLS KAT8 KIAA1199 KRT8P33 LINC00461 LMOD1 MPHOSPH9 MSRA NOV NT5C2 PDE1A PLA2G4B PPTC7 RNF123 RP11-282O18.3 RP11-436D10.3 RP11-462G12.1 SETD8 SF3A3 SLC25A37 SLC9A3R2 STAG3L1 TRAFD1 USP36
Arm fat mass (left) 2.41 28 17 51.5 0.85 8.5e-09 ARNTL CCDC148 CCNE1 CTNNB1 DLG4 DYNC1I2 FIBP IFT57 KAT8 KIAA1199 LINC00461 LMOD1 LOC100129961 MLLT10 MSRA NCF1 PITPNM2 PPP1R3B PPTC7 RERE RNF123 RP11-462G12.1 SLC25A37 SLC9A3R2 SRR STAG3L1 STXBP5 USP36
Number of self-reported non-cancer illnesses 2.81 9 2 6.1 0.97 1.3e-05 ACAD10 ARNTL GMEB2 LSMD1 MLLT10 RP5-1029K10.2 SH2B3 STMN3 TRAFD1
Miserableness 1.75 5 2 6.1 -0.32 6.0e-01 ACP2 MSRA RERE RNF123 RP11-261C10.5
Guilty feelings 1.41 2 0 0.0 0.00 1.0e+00 ARNTL MSRA
Mother's age at death 1.61 1 0 0.0 0.00 1.0e+00 CLCN6
Financial situation satisfaction 1.02 1 0 0.0 0.00 1.0e+00 RNF123
Medication: Blood pressure 5.54 29 19 57.6 0.96 9.1e-19 ACAD10 ACP2 ADM AGT ALDH2 C1GALT1 C4orf22 C6orf174 CERS5 CHP1 CLCN6 DLG4 FES GMEB2 KIAA1199 LSMD1 MANBA MPI MSRA NME6 NRBF2 NT5C2 RP11-436D10.3 SH2B3 SIPA1 TMEM133 TNNT3 TRAFD1 WNT2B
High cholesterol (Self-reported) 1.86 3 1 3.0 0.00 1.0e+00 DCAF16 MPHOSPH9 TMEM133
Medication: Bendroflumethiazide 3.99 14 5 15.2 0.92 3.6e-06 ACP2 ADAMTS7 ATP2B1 C6orf174 CCNE1 FES KIAA1199 MPI MSRA RP11-436D10.3 SH2B3 TMEM133 TNNT3 WNT2B
Medication: Paracetamol 1.58 4 0 0.0 0.98 1.8e-02 MLLT10 NMT1 RP11-261C10.5 U91328.21
Medication: Lisinopril 2.56 2 0 0.0 0.00 1.0e+00 NME6 NRBF2
Illnesses of father: High blood pressure 2.73 3 1 3.0 0.00 1.0e+00 ALDH2 C4orf22 FES
Ever smoked 1.68 2 1 3.0 0.00 1.0e+00 CTNNB1 SRR
Basal metabolic rate 2.26 35 29 87.9 0.08 6.3e-01 ACAD10 ADM ALDH2 BCKDHB CCNE1 CD164 CPEB4 CTNNB1 DCAF16 DYNC1I2 FIBP KAT8 KIAA1199 KRT8P33 LINC00461 LMOD1 MLLT10 MPHOSPH9 MSRA NOV NT5C2 PDE1A PPTC7 RNF123 RP11-282O18.3 RP11-436D10.3 RP11-462G12.1 SETD8 SF3A3 SH2B3 SLC25A37 SLC9A3R2 STAG3L1 TRAFD1 USP36
Leg fat percentage (left) 2.86 33 19 57.6 0.82 4.4e-09 ABCB9 ADM ARNTL CCDC148 CCNE1 CHP1 DCAF16 EDEM3 FIBP HELLS KAT8 LINC00461 LMOD1 LOC100129961 MLLT10 MPHOSPH9 MSRA NCF1 NDUFAF6 NMT1 OIP5-AS1 PITPNM2 PPP1R3B PPTC7 REEP3 RERE RNF123 RP11-462G12.1 SLC25A37 SLC9A3R2 STAG3L1 STMN3 WNT2B
Arm fat-free mass (left) 2.33 33 27 81.8 0.04 8.4e-01 ACAD10 ADM ALDH2 BCKDHB CCNE1 CD164 CTNNB1 DCAF16 DYNC1I2 FIBP KAT8 KIAA1199 KRT8P33 LINC00461 LMOD1 MLLT10 MPHOSPH9 MSRA NOV PDE1A PPTC7 RNF123 RP11-282O18.3 RP11-375I20.6 RP11-462G12.1 SETD8 SF3A3 SH2B3 SLC25A37 SLC9A3R2 STAG3L1 TRAFD1 USP36
Number of operations (self-reported) 1.27 1 0 0.0 0.00 1.0e+00 MLLT10
Average weekly beer plus cider intake 1.27 1 0 0.0 0.00 1.0e+00 RNF123
Irritability 1.56 2 2 6.1 0.00 1.0e+00 LINC00461 MSRA
Risk taking 1.43 2 1 3.0 0.00 1.0e+00 MSRA RP11-261C10.5
Age started oral contraceptive pill 1.10 1 0 0.0 0.00 1.0e+00 RNF123
Vascular/heart problems diagnosed by doctor 6.98 67 41 124.2 -0.98 5.5e-48 AC006111.1 ACAD10 ACP2 ADAM1A AGT ALDH2 ARNTL ATP2B1 C1GALT1 C20orf160 C4orf22 C6orf174 CCDC148 CERS5 CHP1 CLCN6 DCAF16 DLG4 EDEM3 FES FIBP GMEB2 HYI IRAK1BP1 ITGB5 KAT8 KIAA1199 KIF2A LMOD1 LSMD1 MANBA MLLT10 MPI MSRA MTHFR NAA25 NCF1 NDUFAF6 NEIL2 NELFCD NME6 NMT1 NOC3L NRBF2 NSUN6 NT5C2 OIP5-AS1 PDE1A PLA2G4B RERE RP11-261C10.5 RP11-436D10.3 RP5-1029K10.2 RPAP1 RSRC1 RYK SH2B3 SIPA1 SRR STAG3L1 SWAP70 TCEA2 TMEM133 TNNT3 TRAFD1 WNT2B ZKSCAN1
Cholesterol lowering medication 1.78 2 0 0.0 0.00 1.0e+00 DCAF16 GIGYF1
Pain experienced in last month 1.62 2 0 0.0 0.00 1.0e+00 ACAD10 RNF123
Supplements: Calcium 1.27 1 0 0.0 0.00 1.0e+00 REEP3
Basal cell carcinoma (self-reported) 0.95 1 0 0.0 0.00 1.0e+00 RP11-299J3.8
Heart attack/myocardial infarction (self-reported) 1.90 2 0 0.0 0.00 1.0e+00 FES SH2B3
Heart disease (siblings) 1.78 1 0 0.0 0.00 1.0e+00 FES
Pack years of smoking 1.48 2 1 3.0 0.00 1.0e+00 ADAMTS7 PPTC7
Impedance of whole body 1.94 30 21 63.6 -0.23 2.3e-01 ADM C4orf3 CCNE1 CERS5 FIBP GNAO1 HELLS IGFBP3 KIAA1199 KRT8P33 KTN1-AS1 LINC00461 LMOD1 MANBA MSRA NCF1 NOC3L NT5C2 PDE1A PLA2G4B PPP1R3B RNF123 RP11-23P13.4 RP11-23P13.7 RP11-462G12.1 RP11-7I15.3 RP5-1029K10.2 STAG3L1 SWAP70 WNT2B
Leg fat mass (left) 2.75 27 18 54.5 0.78 1.7e-06 ARNTL CCNE1 DYNC1I2 EDEM3 FIBP IFT57 KAT8 KIAA1199 LINC00461 LMOD1 LOC100129961 MLLT10 MSRA NCF1 PITPNM2 PPP1R3B PPTC7 RERE RNF123 RP11-462G12.1 SLC25A37 SLC9A3R2 STAG3L1 STMN3 STXBP5 USP36 WNT2B
Arm predicted mass (left) 2.34 33 26 78.8 0.05 8.0e-01 ACAD10 ADM ALDH2 BCKDHB CCNE1 CD164 CTNNB1 DCAF16 DYNC1I2 FIBP HELLS KAT8 KIAA1199 KRT8P33 LINC00461 LMOD1 MLLT10 MPHOSPH9 MSRA NOV PDE1A PPTC7 RNF123 RP11-282O18.3 RP11-375I20.6 RP11-462G12.1 SF3A3 SH2B3 SLC25A37 SLC9A3R2 STAG3L1 TRAFD1 USP36

Associations by panel

study tissue # hits % hits/tests avg chisq
GTEx Adipose Subcutaneous 51 1.461 3.24
GTEx Adipose Visceral Omentum 38 1.866 3.51
GTEx Adrenal Gland 22 1.510 3.03
GTEx Artery Aorta 50 1.680 3.55
GTEx Artery Coronary 18 1.522 3.40
GTEx Artery Tibial 69 1.835 3.50
GTEx Brain Caudate basal ganglia 12 1.304 3.44
GTEx Brain Cerebellar Hemisphere 25 1.679 3.25
GTEx Brain Cerebellum 30 1.514 3.39
GTEx Brain Cortex 19 1.836 3.25
GTEx Brain Frontal Cortex BA9 17 1.840 3.51
GTEx Brain Hippocampus 2 0.382 3.08
GTEx Brain Hypothalamus 7 1.186 3.11
GTEx Brain Nucleus accumbens basal ganglia 12 1.387 3.24
GTEx Brain Putamen basal ganglia 9 1.442 3.32
GTEx Breast Mammary Tissue 35 1.773 3.34
GTEx Breast Mammary Tissue (Male) 22 1.844 3.23
GTEx Breast Mammary Tissue (Female) 20 1.217 3.16
GTEx Cells EBV-transformed lymphocytes 18 1.265 3.31
GTEx Cells Transformed fibroblasts 58 1.381 3.19
GTEx Colon Sigmoid 23 1.573 3.32
GTEx Colon Transverse 34 1.647 3.25
GTEx Esophagus Gastroesophageal Junction 26 1.799 3.39
GTEx Esophagus Mucosa 53 1.596 3.21
GTEx Esophagus Muscularis 49 1.516 3.24
GTEx Heart Atrial Appendage 21 1.330 3.18
GTEx Heart Left Ventricle 26 1.699 3.29
GTEx Liver 13 1.813 3.02
GTEx Lung 46 1.601 3.31
GTEx Muscle Skeletal 42 1.453 3.19
GTEx Nerve Tibial 69 1.597 3.23
GTEx Ovary 18 1.982 3.59
GTEx Pancreas 30 1.838 3.46
GTEx Pituitary 16 1.435 3.29
GTEx Prostate 17 2.036 3.67
GTEx Skin Not Sun Exposed Suprapubic 43 1.749 3.38
GTEx Skin Sun Exposed Lower leg 57 1.566 3.33
GTEx Small Intestine Terminal Ileum 8 1.735 3.48
GTEx Spleen 13 0.921 3.25
GTEx Stomach 25 1.719 3.49
GTEx Testis 42 1.331 3.15
GTEx Thyroid 56 1.400 3.21
GTEx Uterus 6 1.058 3.08
GTEx Vagina 10 1.575 3.37
GTEx Whole Blood 29 1.455 3.24
METSIM Adipose 38 0.824 2.77
NTR Blood 23 0.958 2.95
ROSMAP Brain Pre-frontal Cortex 74 1.685 3.07
YFS Blood 50 1.083 2.80
CommonMind Brain Pre-frontal Cortex 64 1.191 2.88
TCGA Breast Tumor 9 1.173 3.09
TCGA Breast Normal 40 0.951 2.71
TCGA Ovarian Tumor 29 0.992 2.71
TCGA Prostate Tumor 39 1.127 2.94